Supplementary Figures S1-S3 from Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy

Figure S1. Heat map of drug responses of 220 compounds across 45 HPV negative cell lines. Figure S2. DSS scores and grouping of the used drugs based on their functional categories. Figure S3. An effect of transient knock-down of RAB25 and FAM83H to the cellular response of EGFR inhibitors afatinib and erlotinib.